[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336831-105":59,"doc-detail-336831-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeting-chondroitin-sulfate-suppresses-macropinocytosis-of-breast-cancer-cells-by-modulating-syndecan-1-expression","Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression","","Abnormal chondroitin sulfate (CS) chains accumulate in breast cancer tissue and correlate with poor patient outcomes, yet how these CS structures drive cancer progression has remained unclear, limiting targeted CS-based therapy development. This study links chondroitin polymerizing factor (CHPF)–associated proteoglycans to syndecan-1 (SDC1) regulation and macropinocytosis control. CHPF and SDC1 expression align in primary tumors, and TGF-β signaling connects CHPF/SDC1 regulation. CS–SDC1 stabilization supports macropinocytotic activity under nutrient deprivation. A 6-O-sulfated CS-binding peptide (C6S-p) binds CS–SDC1, promotes SDC1 degradation, suppresses macropinocytosis, and inhibits tumor growth in vivo.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeting-chondroitin-sulfate-suppresses-macropinocytosis-of-breast-cancer-cells-by-modulating-syndecan-1-expression/336831/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeting-chondroitin-sulfate-suppresses-macropinocytosis-of-breast-cancer-cells-by-modulating-syndecan-1-expression/336831.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CHPF play in breast cancer progression according to this study?","Question",{"text":112,"@type":113},"CHPF regulates CS accumulation and supports CS–SDC1 stabilization on the cancer cell surface, which in turn modulates macropinocytotic activity under nutrient-deprived conditions. High CHPF expression is associated with worse patient prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is syndecan-1 (SDC1) connected to macropinocytosis in breast cancer cells?",{"text":117,"@type":113},"The study examines CHPF–SDC1 regulation at both protein and RNA levels and shows that CHPF supports CS–SDC1 stabilization, which enhances macropinocytotic activity. Suppressing the pathway leads to reduced macropinocytosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What effect does the 6-O-sulfated CS-binding peptide (C6S-p) have?",{"text":121,"@type":113},"C6S-p binds CS–SDC1, increases SDC1 degradation, suppresses macropinocytosis of breast cancer cells, and inhibits tumor growth in vivo.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336831,1790874624,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression  \nHung-Rong Yen 1,2, Wen-Chieh Liao3,4, Chia-Hua Chen5, Ying-Ai Su3,6, Ying-Wei Huang3,6, Chi Hsiao3,6, Yu-Lun Chou3, Yin-Hung Chu3, Pin-Keng Shih3,7,8 and Chiung-Hui Liu3,4   \n1 Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan  \n2 Chinese Medicine Research Center, and School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan  \n3 Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan  \n4 Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan  \n5 Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan  \n6 College of Medicine, Chung Shan Medical University, Taichung, Taiwan  \n7 Department of Surgery, China Medical University Hospital, Taichung, Taiwan  \n8 School of Medicine, China Medical University, Taichung, Taiwan  \nKeywords  \nbreast cancer; chondroitin sulfate; CHPF; macropinocytosis; syndecan 1  \nCorrespondence  \nC.-H. Liu, College of Medicine, National Chung Hsing University, 145 Xingda Rd. , South Dist., Taichung City 402202, Taiwan (R.O.C.)  \nTel: +886 4 22840450 \\# 6141  \nE-mail: [chiunghui.liu@gmail.com](chiunghui.liu@gmail.com), [chiunghui@nchu.edu.tw](chiunghui@nchu.edu.tw)  \nHung-Rong Yen and Wen-Chieh Liao contributed equally to this article  \n(Received 26 December 2023, revised 2 April 2024, accepted 8 May 2024, available online 21 May 2024)  \ndoi:10 . 1002/1878-0261 .13667  \nAccumulation of abnormal chondroitin sulfate (CS) chains in breast cancer tissue is correlated with poor prognosis. However, the biological functions of these CS chains in cancer progression remain largely unknown, impeding the development of targeted treatment focused on CS. Previous studies identiﬁed chondroitin polymerizing factor (CHPF; also known as chondroitin sulfate synthase 2) is the critical enzyme regulating CS accumulation in breast cancer tissue. We then assessed the association between CHPF-associated proteoglycans (PGs) and signaling pathways in breast cancer datasets. The regulation between CHPF and syndecan 1 (SDC1) was examined at both the protein and RNA levels. Confocal microscopy and image ﬂow cytometry were employed to quantify macropinocytosis. The effects of the 6-O-sulfated CS-binding peptide (C6S-p) on blocking CS functions were tested in vitro and in vivo. Results indicated that the expression of CHPF and SDC1 was tightly associated within primary breast cancer tissue, and high expression of both genes exacerbated patient prognosis. Transforming growth factor beta (TGF-b) signaling was implicated in the regulation of CHPF and SDC1 in breast cancer cells. CHPF supported CS–SDC1 stabilization on the cell surface, modulating macropinocytotic activity in breast cancer cells under nutrient-deprived conditions. Furthermore, C6S-p demonstrated the ability to bind CS-SDC1, increase SDC1 degradation, suppress macropinocytosis of breast cancer cells, and inhibit tumor growth in vivo. Although other PGs may also be involved in CHPF-regulated breast cancer malignancy, this study provides the ﬁrst evidence that a CS synthase participates in the regulation of macropinocytosis in cancer cells by supporting SDC1 expression on cancer cells.  \nAbbreviations  \nC6S-p, 6-O-sulfated chondroitin sulfate-binding peptide; ChaseABC, chondroitinase ABC; CHPF, chondroitin polymerizing factor; CHX, cycloheximide; CS, chondroitin sulfate; CSPG, chondroitin sulfate proteoglycan; ECM, extracellular matrix; EIPA, 5-[N-ethyl-N-isopropyl] amiloride; FBS, fetal bovine serum; GAG, glycosaminoglycan; GalNAc, N-acetylgalactosamine; HS, heparan sulfate; Hsase, heparinase; HSPG, heparan sulfate proteoglycan; PG, proteoglycan; scRNA-seq, single-cell RNA sequence; SDC1, syndecan 1; ssGSEA, single-sample gene se","cbCaihWeOigOG2pm","https://ap.wps.com/l/cbCaihWeOigOG2pm","pdf",3085700,17,"English","# Introduction\n## Tumor microenvironment and glycan composition\n## Glycosaminoglycans and proteoglycans in breast cancer\n## CHPF as a CS synthase and clinical relevance","[{\"question\":\"What role does CHPF play in breast cancer progression according to this study?\",\"answer\":\"CHPF regulates CS accumulation and supports CS–SDC1 stabilization on the cancer cell surface, which in turn modulates macropinocytotic activity under nutrient-deprived conditions. High CHPF expression is associated with worse patient prognosis.\"},{\"question\":\"How is syndecan-1 (SDC1) connected to macropinocytosis in breast cancer cells?\",\"answer\":\"The study examines CHPF–SDC1 regulation at both protein and RNA levels and shows that CHPF supports CS–SDC1 stabilization, which enhances macropinocytotic activity. Suppressing the pathway leads to reduced macropinocytosis.\"},{\"question\":\"What effect does the 6-O-sulfated CS-binding peptide (C6S-p) have?\",\"answer\":\"C6S-p binds CS–SDC1, increases SDC1 degradation, suppresses macropinocytosis of breast cancer cells, and inhibits tumor growth in vivo.\"}]","Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression | PDF",1790016795,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/280861a0fe371929670053628e3d98f8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a9da212ad09f9bbf9127cee7e989a9c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bc5b521c435e511b730544d841f3ecd.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06c304c408b9e007b4495ce1330c5430.webp",980,1287]